Synvect is a biotechnology startup committed to eliminating vector-borne diseases through scalable, precision-driven mosquito suppression technology. Founded by scientists from UC San Diego, Synvect leverages CRISPR innovations to provide a safe, effective alternative to chemical pesticides.
Market
Vector-borne disease control
Location
San Diego,
CA,
USA
Coinvestors
Antler, Bill & Melinda Gates Foundation, NuFund Venture, Redbud